Annual Net Margin
-21.47%
+27.24%+55.92%
31 December 2023
Summary:
Rigel Pharmaceuticals annual net profit margin is currently -21.47%, with the most recent change of +27.24% (+55.92%) on 31 December 2023. During the last 3 years, it has risen by +5.91% (+21.59%). RIGL annual net margin is now -170.83% below its all-time high of 30.31%, reached on 31 December 2010.RIGL Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
22.46%
+25.26%+902.14%
30 September 2024
Summary:
Rigel Pharmaceuticals quarterly net profit margin is currently 22.46%, with the most recent change of +25.26% (+902.14%) on 30 September 2024. Over the past year, it has increased by +42.69% (+211.02%). RIGL quarterly net margin is now -67.81% below its all-time high of 69.77%, reached on 30 September 2010.RIGL Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RIGL Net Margin Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +55.9% | +211.0% |
3 y3 years | +21.6% | +123.1% |
5 y5 years | +86.4% | +140.8% |
RIGL Net Margin High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -78.9% | +55.9% | at high | +113.7% |
5 y | 5 years | -78.9% | +86.4% | -53.9% | +113.7% |
alltime | all time | -170.8% | +99.9% | -67.8% | +100.4% |
Rigel Pharmaceuticals Net Margin History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | 22.46%(-902.1%) |
June 2024 | - | -2.80%(-90.0%) |
Mar 2024 | - | -27.92%(-1455.3%) |
Dec 2023 | -21.47%(-55.9%) | 2.06%(-110.2%) |
Sept 2023 | - | -20.23%(-17.6%) |
June 2023 | - | -24.55%(-52.7%) |
Mar 2023 | - | -51.92%(-2001.8%) |
Dec 2022 | -48.71%(+305.9%) | 2.73%(-103.2%) |
Sept 2022 | - | -84.95%(+87.7%) |
June 2022 | - | -45.25%(-72.4%) |
Mar 2022 | - | -164.00%(+47.8%) |
Dec 2021 | -12.00%(-56.2%) | -110.94%(+14.1%) |
Sept 2021 | - | -97.26%(+84.8%) |
June 2021 | - | -52.62%(-207.9%) |
Mar 2021 | - | 48.75%(-146.8%) |
Dec 2020 | -27.38%(-75.7%) | -104.27%(+35.3%) |
Sept 2020 | - | -77.08%(-29.7%) |
June 2020 | - | -109.71%(-388.0%) |
Mar 2020 | - | 38.10%(-134.1%) |
Dec 2019 | -112.83%(-28.7%) | -111.69%(+102.7%) |
Sept 2019 | - | -55.09%(-72.2%) |
June 2019 | - | -198.00%(+42.0%) |
Mar 2019 | - | -139.40%(-1734.2%) |
Dec 2018 | -158.35%(-90.9%) | 8.53%(-101.7%) |
Sept 2018 | - | -488.51%(-65.8%) |
June 2018 | - | -1430.16%(-27.1%) |
Dec 2017 | -1739.34%(+412.2%) | - |
Sept 2017 | - | -1962.22%(+359.2%) |
Mar 2017 | - | -427.29%(-17.8%) |
Dec 2016 | -339.58%(+90.7%) | -519.67%(-13.7%) |
Sept 2016 | - | -601.84%(+282.2%) |
June 2016 | - | -157.47%(-54.7%) |
Mar 2016 | - | -347.27%(+133.7%) |
Dec 2015 | -178.11%(-83.8%) | -148.61%(+189.5%) |
Sept 2015 | - | -51.34%(-80.9%) |
June 2015 | - | -268.36%(-67.9%) |
Mar 2015 | - | -835.31%(+184.9%) |
Dec 2014 | -1101.92%(-11.5%) | - |
Dec 2013 | -1245.13%(-71.7%) | -293.23%(-82.0%) |
June 2013 | - | -1626.29%(-1.4%) |
Dec 2012 | -4392.89% | - |
Date | Annual | Quarterly |
---|---|---|
June 2012 | - | -1649.20%(-46.6%) |
Mar 2012 | - | -3089.87%(+650.5%) |
Dec 2011 | -1809.96%(-6071.5%) | - |
Sept 2011 | - | -411.73%(-92.4%) |
June 2011 | - | -5436.46%(-7892.0%) |
Dec 2010 | 30.31%(-100.2%) | - |
Sept 2010 | - | 69.77%(+27.7%) |
June 2010 | - | 54.65%(-108.0%) |
Mar 2010 | - | -684.85%(-79.5%) |
Dec 2009 | -14.87 K%(+2423.1%) | -3345.73%(+1308.6%) |
Dec 2007 | -589.46%(+424.2%) | -237.53%(-75.9%) |
June 2007 | - | -983.90%(+52.3%) |
Mar 2007 | - | -646.03%(+30.7%) |
Dec 2006 | -112.44%(-58.9%) | -494.12%(+166.0%) |
Sept 2006 | - | -185.77%(+1041.8%) |
June 2006 | - | -16.27%(-81.0%) |
Mar 2006 | - | -85.57%(-42.1%) |
Dec 2005 | -273.85%(-77.0%) | -147.72%(-62.4%) |
Sept 2005 | - | -393.24%(+47.3%) |
June 2005 | - | -266.89%(-37.4%) |
Mar 2005 | - | -426.43%(-68.1%) |
Dec 2004 | -1188.57%(+219.0%) | -1338.73%(-45.3%) |
Sept 2004 | - | -2448.56%(+195.0%) |
June 2004 | - | -829.99%(-5.4%) |
Mar 2004 | - | -877.67%(+55.8%) |
Dec 2003 | -372.65%(+58.9%) | -563.25%(+7.0%) |
Sept 2003 | - | -526.34%(+18.1%) |
June 2003 | - | -445.55%(+156.9%) |
Mar 2003 | - | -173.45%(-20.5%) |
Dec 2002 | -234.55%(+50.8%) | -218.11%(-21.4%) |
Sept 2002 | - | -277.63%(+15.3%) |
June 2002 | - | -240.86%(+17.9%) |
Mar 2002 | - | -204.29%(+59.8%) |
Dec 2001 | -155.56%(-18.9%) | -127.87%(-13.5%) |
Sept 2001 | - | -147.86%(-36.9%) |
June 2001 | - | -234.23%(+79.8%) |
Mar 2001 | - | -130.24%(-27.5%) |
Dec 2000 | -191.86%(+39.4%) | -179.66%(-8.2%) |
Sept 2000 | - | -195.77%(0.0%) |
June 2000 | - | -195.77%(0.0%) |
Mar 2000 | - | -195.77% |
Dec 1999 | -137.64% | - |
FAQ
- What is Rigel Pharmaceuticals annual net profit margin?
- What is the all time high annual net margin for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals annual net margin year-on-year change?
- What is Rigel Pharmaceuticals quarterly net profit margin?
- What is the all time high quarterly net margin for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals quarterly net margin year-on-year change?
What is Rigel Pharmaceuticals annual net profit margin?
The current annual net margin of RIGL is -21.47%
What is the all time high annual net margin for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high annual net profit margin is 30.31%
What is Rigel Pharmaceuticals annual net margin year-on-year change?
Over the past year, RIGL annual net profit margin has changed by +27.24% (+55.92%)
What is Rigel Pharmaceuticals quarterly net profit margin?
The current quarterly net margin of RIGL is 22.46%
What is the all time high quarterly net margin for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high quarterly net profit margin is 69.77%
What is Rigel Pharmaceuticals quarterly net margin year-on-year change?
Over the past year, RIGL quarterly net profit margin has changed by +42.69% (+211.02%)